161 related articles for article (PubMed ID: 18710917)
1. In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.
Li CR; Yang XY; Lou RH; Zhang WX; Wang YM; Yuan M; Li Y; Chen HZ; Hong B; Sun CH; Zhao LX; Li ZR; Jiang JD; You XF
Antimicrob Agents Chemother; 2008 Nov; 52(11):3875-82. PubMed ID: 18710917
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of vertilmicin to modifications by three types of recombinant aminoglycoside-modifying enzymes.
Yuan M; Han H; Li CR; Yang XY; Li GQ; Cen S; Kang XX; Si SY; Jiang JD; You XF
Antimicrob Agents Chemother; 2011 Aug; 55(8):3950-3. PubMed ID: 21646489
[TBL] [Abstract][Full Text] [Related]
3. In vivo antibacterial activity of vertilmicin, a new aminoglycoside antibiotic.
You XF; Li CR; Yang XY; Yuan M; Zhang WX; Lou RH; Wang YM; Li GQ; Chen HZ; Song DQ; Sun CH; Cen S; Yu LY; Zhao LX; Jiang JD
Antimicrob Agents Chemother; 2009 Oct; 53(10):4525-8. PubMed ID: 19635958
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of netilmicin, gentamicin, and amikacin.
Kantor RJ; Norden CW
Antimicrob Agents Chemother; 1977 Jan; 11(1):126-31. PubMed ID: 402104
[TBL] [Abstract][Full Text] [Related]
5. Novel aminoglycoside 2''-phosphotransferase identified in a gram-negative pathogen.
Toth M; Frase H; Antunes NT; Vakulenko SB
Antimicrob Agents Chemother; 2013 Jan; 57(1):452-7. PubMed ID: 23129050
[TBL] [Abstract][Full Text] [Related]
6. The major aminoglycoside-modifying enzyme AAC(3)-II found in Escherichia coli determines a significant disparity in its resistance to gentamicin and amikacin in China.
Xiao Y; Hu Y
Microb Drug Resist; 2012 Feb; 18(1):42-6. PubMed ID: 22066787
[TBL] [Abstract][Full Text] [Related]
7. Carbapenem-resistant Klebsiella pneumoniae strains exhibit diversity in aminoglycoside-modifying enzymes, which exert differing effects on plazomicin and other agents.
Almaghrabi R; Clancy CJ; Doi Y; Hao B; Chen L; Shields RK; Press EG; Iovine NM; Townsend BM; Wagener MM; Kreiswirth B; Nguyen MH
Antimicrob Agents Chemother; 2014 Aug; 58(8):4443-51. PubMed ID: 24867988
[TBL] [Abstract][Full Text] [Related]
8. Enzymatic modification of aminoglycoside antibiotics in gentamicin-resistant gram-negative bacteria.
Kettner M; Navarová J; Lebek G; Krcméry V
Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Aug; 257(3):372-82. PubMed ID: 6091367
[TBL] [Abstract][Full Text] [Related]
9. Preclinical comparative evaluation of aminoglycosides.
Abbate GF; Alagia I; Giaquinto E; Giordano B; Leonessa V; Altucci P
Chemioterapia; 1984 Dec; 3(6):378-84. PubMed ID: 6529780
[TBL] [Abstract][Full Text] [Related]
10. Occurrence of aminoglycoside-modifying-enzyme genes aac(6')-aph(2"), aph(3'), ant(4') and ant(6) in clinical isolates of Enterococcus faecalis resistant to high-level of gentamicin and amikacin.
Filipová M; Bujdákova H; Drahovská H; Lisková A; Hanzen J
Folia Microbiol (Praha); 2006; 51(1):57-61. PubMed ID: 16821713
[TBL] [Abstract][Full Text] [Related]
11. Identification of aminoglycoside-modifying enzymes by susceptibility testing: epidemiology of methicillin-resistant Staphylococcus aureus in Japan.
Ida T; Okamoto R; Shimauchi C; Okubo T; Kuga A; Inoue M
J Clin Microbiol; 2001 Sep; 39(9):3115-21. PubMed ID: 11526138
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of dactimicin and other aminoglycosides against bacteria producing aminoglycoside-modifying enzymes.
Felmingham D; Jones K
Drugs Exp Clin Res; 1989; 15(3):133-6. PubMed ID: 2752913
[TBL] [Abstract][Full Text] [Related]
13. Changes in resistance to aminoglycoside antibiotics of different bacterial strains isolated during the period 1978 to 1983. Netilmicin as alternative therapy.
Bovelacci A; Montini G; Ramacciotti PG
Chemioterapia; 1985 Dec; 4(6):439-44. PubMed ID: 3830413
[TBL] [Abstract][Full Text] [Related]
14. Trends in the gentamicin and arbekacin susceptibility of methicillin-resistant Staphylococcus aureus and the genes encoding aminoglycoside-modifying enzymes.
Barada K; Hanaki H; Ikeda S; Yamaguchi Y; Akama H; Nakae T; Inamatsu T; Sunakawa K
J Infect Chemother; 2007 Apr; 13(2):74-8. PubMed ID: 17458673
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility of aerobic gram-negative bacilli to aminoglycosides. Effects of 45 months of amikacin as first-line aminoglycoside therapy.
Saavedra S; Vera D; Ramírez-Ronda CH
Am J Med; 1986 Jun; 80(6B):65-70. PubMed ID: 3014877
[TBL] [Abstract][Full Text] [Related]
16. Transposon Tn5281 is the main distributor of the aminoglycoside modifying enzyme gene among isolates of Enterococcus faecalis in Tehran hospitals.
Feizabadi MM; Shokrzadeh L; Sayady S; Asadi S
Can J Microbiol; 2008 Oct; 54(10):887-90. PubMed ID: 18923558
[TBL] [Abstract][Full Text] [Related]
17. [Estimation of level of aminoglycosides susceptibility of bacterial strains isolated from patients with systemic and general infections].
Kowalska-Krochmal B; Dolna I; Dobosz A; Wrzyszcz E; Gościniak G
Med Dosw Mikrobiol; 2008; 60(3):205-14. PubMed ID: 19143174
[TBL] [Abstract][Full Text] [Related]
18. Molecular epidemiology of high-level aminoglycoside-resistant enterococci isolated from patients in a university hospital in southern Italy.
Zarrilli R; Tripodi MF; Di Popolo A; Fortunato R; Bagattini M; Crispino M; Florio A; Triassi M; Utili R
J Antimicrob Chemother; 2005 Nov; 56(5):827-35. PubMed ID: 16186168
[TBL] [Abstract][Full Text] [Related]
19. Comparison of in vitro activity of Sch 21420, a gentamicin B derivative, with those of amikacin, gentamicin, netilmicin, sisomicin, and tobramycin.
Thornsberry C; Barry AL; Jones RN; Baker CN; Badal RE; Packer RR
Antimicrob Agents Chemother; 1980 Aug; 18(2):338-45. PubMed ID: 7447410
[TBL] [Abstract][Full Text] [Related]
20. [The role of aminoglycoside--modifying enzymes in resistance of Gram-negative rods].
Jakoniuk P; Wieczorek P; Sacha PT; Zalewska M; Leszczyńska K
Med Dosw Mikrobiol; 2006; 58(4):363-70. PubMed ID: 17642314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
